UBS Starts Inovalon Holdings (INOV) at Buy

Citi Starts Inovalon Holdings (INOV) at Neutral

Citi initiated coverage on Inovalon Holdings (NASDAQ: INOV) with a Neutral rating and a price target of $31.00.

For an analyst ratings summary and ratings history on Inovalon Holdings click here. For more ratings news on Inovalon Holdings click here.

Shares of Inovalon Holdings closed at $30.53 yesterday.

Goldman Sachs Starts Inovalon Holdings (INOV) at Neutral

Goldman Sachs initiated coverage on Inovalon Holdings (NASDAQ: INOV) with a Neutral rating and a price target of $30.00.

For an analyst ratings summary and ratings history on Inovalon Holdings click here. For more ratings news on Inovalon Holdings click here.

Shares of Inovalon Holdings closed at $30.53 yesterday.

Baird Starts Inovalon Holdings (INOV) at Outperform

Baird initiated coverage on Inovalon Holdings (NASDAQ: INOV) with an Outperform rating and a price target of $36.00.

For an analyst ratings summary and ratings history on Inovalon Holdings click here. For more ratings news on Inovalon Holdings click here.

Shares of Inovalon Holdings closed at $30.53 yesterday.

William Blair Starts Inovalon Holdings (INOV) at Outperform

William Blair initiated coverage on Inovalon Holdings (NASDAQ: INOV) with an Outperform rating.

For an analyst ratings summary and ratings history on Inovalon Holdings click here. For more ratings news on Inovalon Holdings click here.

Shares of Inovalon Holdings closed at $30.53 yesterday.

Piper Jaffray Starts Inovalon Holdings (INOV) at Neutral

Piper Jaffray initiates coverage on Inovalon Holdings (NASDAQ: INOV) with a Neutral rating and a price target of $31.00.

Analyst Sean Wieland commented, "Inovalon is an integrated stack of health care data analytics and interventional processes that combined deliver risk adjustment and regulatory reporting... More

BofA/Merrill Lynch Starts Inovalon Holdings (INOV) at Neutral

BofA/Merrill Lynch initiates coverage on Inovalon Holdings (NASDAQ: INOV) with a Neutral rating and a price target of $33.00.

Analyst Robert Willoughby said while the company's analytics capabilities are unmatched in terms of insight and processing speed, with shares up 13.1% since its February 11... More